Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Inovio’s Coronavirus Vaccine Makes INO Stock Worth a Bet

Speculators are betting that INO stock and its vaccine are coronavirus killers, but the biotechnology firm may be more than just that.

A Massive Market Opportunity Makes FuelCell Worth the Speculation

FuelCell is risky, but speculators still love it. FCEL stock will be a great buy if it posts consistent revenue and market share growth.

Get Creative and Buy the Dip in Pinterest as User Activity Surges

Pinterest continues to draw active users and boost relevant advertising on its site, making Pinterest stock a buy on the dip now.

Canopy Growth’s Future Is Still Very Bright

Canopy Growth reported strong sales numbers and updated investors on its U.S. expansion. CGC stock still looks bright.

New Financing Deals Will Improve Nio’s Long-Term Business

Nio stock looks better in the long term thanks to two new cash raises that add $200 million to the company's pocketbooks.

Chesapeake Energy Offers a Juicy Play to Speculative Investors

Natural gas prices are at a multi-year low, keeping CHK stock at penny status. But a rebound in prices could bring double-digit gains.

7 5G Stocks to Buy Now for the Future

5G deployment is underway. Investors who ignore this trend are missing its potential as 5G growth accelerates in the next few years.

7 Autonomous Vehicle Stocks to Drive You to the Future

Technology firms are expanding beyond computer and mobile markets for growth. Autnomous vehicles are the next area driving the future.

Moderna Will Rebound, But Wait for a Dip Lower to Buy Shares

A secondary offering put downward pressure on Moderna stock that will soon ease up. But wait for a dip toward $15 to buy shares.

7 Micro-Cap Stocks That Could Double

Hidden gem micro-cap stocks are hard to find, unless savvy investors screen for value and strong revenue growth.